Abstract
The pandemic induced lockdown lead to supply and manufacturing disruptions that were swiftly dealt with by the Indian Pharma Industry through successful industry-government collaboration. By May 2020 production was back to normal and exports were higher than the same period in May 2019. The case deals with the processes that enabled this to happen, the policy responses and the changes that happened in the period from March 2020 to August 2020.
Additional Information
Product Type | Case |
---|---|
Reference No. | PSG0139 |
Title | Dealing with the Corona Virus: The Case of the Pharma Industry |
Pages | 46 |
Published on | Apr 12, 2021 |
Year of Event | 2020 |
Authors | Sahay, Arvind; Joshi, Varuna M.; |
Area | Public Systems Group (PSG) |
Discipline | Public Policy and Law |
Sector | Government, Health, Trade |
Learning Objective | To understand the functions and structure of governing regulatory bodies with respect to the Indian pharmaceutical industry. To understand the structure of the pharmaceutical industry. To understand the mechanisms of interaction between the industry and the government. To follow the events that lead up to the pandemic and the government's response. To understand the operational and strategic issues that occurred during the lockdown. |
Keywords | Government-Industry Collaboration; Public Policy; Indian Pharma Industry; Pandemic Management |
Country | India |
Access | For All |
My Cart
You have no items
in your shopping cart.